36120935|t|Development of surface modified bilosomes for the oral delivery of quercetin: optimization, characterization in-vitro antioxidant, antimicrobial, and cytotoxicity study.
36120935|a|Quercetin (QT) is a flavonoid that exhibits anti-oxidant and chemo-preventive activity. This research work aimed to develop surface-modified bilosomes (BS) of QT. The BS was prepared by the solvent evaporation method and optimized by the Box-Behnken design. The optimized QT-BS (QT-BS3opt) displayed vesicle size (143.51 nm), PDI (0.256), zeta potential (-15.4 mV), and entrapment efficiency (89.52%). Further, the optimized QT-BS formulation was coated with chitosan (CS). The XRD diffractogram of CS-QT-BS3opt1 did not exhibit extensive peaks of QT, revealing that QT is properly encapsulated in the polymer matrix. The QT-BS3opt and CS-QT-BS3opt1 exhibited sustained-release (86.62 +- 3.23% and 69.32 +- 2.57%, respectively) up to 24 h with the Korsmeyer-Peppas kinetic model (R2 =0.9089). CS-QT-BS3opt1 exhibited significantly (P < .05) high flux, i.e. 4.20-fold more than pure QT dispersion and 1.27-fold higher than QT-BS3opt. CS-QT-BS3opt1 showed significantly greater bio-adhesion (76.43 +- 2.42%) than QT-BS3opt (20.82 +- 1.45%). The antioxidant activity showed that QT from CS-QT-BS3opt1 has more remarkable (P < .05) antioxidant activity at each concentration than pure QT. The CS-QT-BS3opt1 exhibited 1.61-fold higher cytotoxicity against MFC7 and 1.44-fold higher cytotoxicity against MDA-MB-231 than pure QT. The CS-QT-BS3opt1 displayed a significantly greater antimicrobial potential against E. coli than against S. aureus. From all these findings, it could be concluded that surface-modified QT-BS might be an effective approach for increasing the efficacy of QT in the treatment of certain ailments.
36120935	67	76	quercetin	Chemical	MESH:D011794
36120935	150	162	cytotoxicity	Disease	MESH:D064420
36120935	170	179	Quercetin	Chemical	MESH:D011794
36120935	181	183	QT	Chemical	MESH:D011794
36120935	190	199	flavonoid	Chemical	MESH:D005419
36120935	329	331	QT	Chemical	MESH:D011794
36120935	442	447	QT-BS	Chemical	-
36120935	449	451	QT	Chemical	MESH:D011794
36120935	595	600	QT-BS	Chemical	-
36120935	629	637	chitosan	Chemical	MESH:D048271
36120935	639	641	CS	Chemical	MESH:D048271
36120935	669	674	CS-QT	Chemical	-
36120935	675	682	BS3opt1	CellLine	CVCL:QW64
36120935	718	720	QT	Chemical	MESH:D011794
36120935	737	739	QT	Chemical	MESH:D011794
36120935	772	779	polymer	Chemical	MESH:D011108
36120935	792	794	QT	Chemical	MESH:D011794
36120935	806	811	CS-QT	Chemical	-
36120935	812	819	BS3opt1	CellLine	CVCL:QW64
36120935	963	968	CS-QT	Chemical	-
36120935	969	976	BS3opt1	CellLine	CVCL:QW64
36120935	1052	1054	QT	Chemical	MESH:D011794
36120935	1092	1094	QT	Chemical	MESH:D011794
36120935	1103	1108	CS-QT	Chemical	-
36120935	1109	1116	BS3opt1	CellLine	CVCL:QW64
36120935	1181	1183	QT	Chemical	MESH:D011794
36120935	1246	1248	QT	Chemical	MESH:D011794
36120935	1254	1259	CS-QT	Chemical	-
36120935	1260	1267	BS3opt1	CellLine	CVCL:QW64
36120935	1351	1353	QT	Chemical	MESH:D011794
36120935	1359	1364	CS-QT	Chemical	-
36120935	1365	1372	BS3opt1	CellLine	CVCL:QW64
36120935	1400	1412	cytotoxicity	Disease	MESH:D064420
36120935	1421	1425	MFC7	CellLine	CVCL:5J48
36120935	1447	1459	cytotoxicity	Disease	MESH:D064420
36120935	1468	1478	MDA-MB-231	CellLine	CVCL:0062
36120935	1489	1491	QT	Chemical	MESH:D011794
36120935	1497	1502	CS-QT	Chemical	-
36120935	1503	1510	BS3opt1	CellLine	CVCL:QW64
36120935	1577	1584	E. coli	Species	562
36120935	1598	1607	S. aureus	Species	
36120935	1678	1683	QT-BS	Chemical	-
36120935	1746	1748	QT	Chemical	MESH:D011794
36120935	1777	1785	ailments	Disease	
36120935	Association	MESH:D011794	MESH:D048271

